As a direct result of advocacy by the AADA, CMS will exercise enforcement discretion on several provisions of its revised CLIA laboratory director policy that had excluded board-certified ...

With the registration, the analyzer can be used for clinical testing in South Korea, expanding Quanterix's reach in that country's in vitro diagnostic and clinical laboratory markets.

The Jefferson County Coroner/Medical Examiner’s Office has unveiled its new state-of-the-art facility, a $30 million project ...

The global biomarkers market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

A team of Indian American scientists led by Pallavi Gopal are working to learn more about the dynamics of a protein to help ...

Northwestern Medicine scientists have uncovered key details about a group of rare but serious blood disorders, which may help ...

Instem's commitment to a more flexible, future-ready environment is further reinforced by Provantis' growing suite of APIs connecting to 19 different data domains. This includes enhanced Pathology ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

A biomedical scientist is retiring after more than four decades in pathology, having initially applied for a trainee role on a whim 42 years ago.

A rare gene mutation that delays Alzheimer's disease does so by damping inflammatory signaling in brain-resident immune cells ...

Insight Molecular Diagnostics (Nasdaq: IMDX) moved its headquarters from Irvine, Calif., to Nashville, Tenn., in June 2025. The company’s new NASDAQ symbol became effective June 18. Investors may ...